Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros

Ano de publicação
Tipo de documento
Intervalo de ano
1.
International Journal of Pharmaceutical and Clinical Research ; 14(12):379-386, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2277896

RESUMO

Background: Covid-19 has dramatically changed everyday life across the globe. Otorhinolaryngologists were at the forefront of being exposed to the virus. As the virus evolved so did the practice of otorhinolaryngology in the country. Some innovative tacks for protecting otorhinolaryngologists and improving patient care were put into our practice by many doctors. Assessment of these techniques will help us to overcome the difficulties if a similar situation arises in the future. Material(s) and Method(s): An online survey was conducted among Indian otorhinolaryngologists. The invitation to participate in the survey was circulated among otolaryngology consultants and postgraduates all over India through multiple modalities on social media. The survey consisted of 4 sections with a total of 24 questions, related to covid vaccination status, changes made in practice, OPD (outpatient department) consultations during the lockdown period, and modifications done in outpatient and operation theatre setups. Google forms were kept open for one month. Result(s): There were changes in outpatient and operation procedure management like screening of patients before treatment and surgery, patient health care declarations, vaccination status, improvisation done in the methods of sterilization of ENT instruments, endoscopes, case selection of elective OT (operation theatre) cases. This paper aims to give a brief overview of current knowledge about the impact of covid 19 on otolaryngology practice using the best available evidence. Conclusion(s): COVID-19 had made crucial changes in ENT practice forever which will help otorhinolaryngologists in the better care of patients if a similar situation arises in the future.Copyright © 2022, Dr Yashwant Research Labs Pvt Ltd. All rights reserved.

2.
International Journal of Pharmaceutical and Clinical Research ; 15(1):18-24, 2023.
Artigo em Inglês | EMBASE | ID: covidwho-2234774

RESUMO

Introduction: Otorhinolaryngological manifestations in COVID-19 were not rare and not much emphasized. The aim was to know the prevalence of Otorhinolaryngological manifestations among confirmed SARS-CoV-2 patients in a tertiary care hospital, Northern Kerala. The objectives were to study Otorhinolaryngological problems during COVID and post COVID period and to determine the duration and recovery of smell/taste disturbances. Materials: This was a prospective study of 470 covid-19 patients (categorized into A, B and C as per COVID severity classification by WHO), from March-01-2021 to June-30-2021 in a tertiary care hospital. A pretested semi-structured questionnaire was administered via telephonic interview after explaining the purpose of study and obtaining verbal consent. It included history of ENT symptoms, olfactory and gustatory function. Patients who were unresponsive, unsound and unreachable were excluded. Chi-Square test was used for statistical analysis;p value< 0.05 was considered as significant. Result(s): In this study, 241(51%) were males and 229(49%) were females, 61 (13%) patients in category-A, 329(70%) in category-B and 80(17%) in category-C. The commonest symptoms were anosmia/ hyposmia (80%), headache (74.89%), ageusia/ dysgeusia (76.38%), cough (71.3%). Commonest problems in post-covid period were dyspnea (51.5%), anosmia/ hyposmia (42.1%) and ageusia/ dysgeusia (76.38%). 8.4% and 7.7% of patients were not recovered from smell and taste disturbances during this period. Conclusion(s): Results showed that the commonest symptoms were headache, anosmia, ageusia, cough and dyspnea. This study confirmed high prevalence of smell/taste disorders in COVID-19 infection with self-recovery among half of the cases after nearly 2 weeks. Hence the symptoms could be considered as early identifiers/ markers and those helped in early detection and isolation of the patients for further management. Copyright © 2023, Dr Yashwant Research Labs Pvt Ltd. All rights reserved.

3.
International Journal of Pharmaceutical and Clinical Research ; 15(1):18-24, 2023.
Artigo em Inglês | EMBASE | ID: covidwho-2218937

RESUMO

Introduction: Otorhinolaryngological manifestations in COVID-19 were not rare and not much emphasized. The aim was to know the prevalence of Otorhinolaryngological manifestations among confirmed SARS-CoV-2 patients in a tertiary care hospital, Northern Kerala. The objectives were to study Otorhinolaryngological problems during COVID and post COVID period and to determine the duration and recovery of smell/taste disturbances. Materials: This was a prospective study of 470 covid-19 patients (categorized into A, B and C as per COVID severity classification by WHO), from March-01-2021 to June-30-2021 in a tertiary care hospital. A pretested semi-structured questionnaire was administered via telephonic interview after explaining the purpose of study and obtaining verbal consent. It included history of ENT symptoms, olfactory and gustatory function. Patients who were unresponsive, unsound and unreachable were excluded. Chi-Square test was used for statistical analysis;p value< 0.05 was considered as significant. Result(s): In this study, 241(51%) were males and 229(49%) were females, 61 (13%) patients in category-A, 329(70%) in category-B and 80(17%) in category-C. The commonest symptoms were anosmia/ hyposmia (80%), headache (74.89%), ageusia/ dysgeusia (76.38%), cough (71.3%). Commonest problems in post-covid period were dyspnea (51.5%), anosmia/ hyposmia (42.1%) and ageusia/ dysgeusia (76.38%). 8.4% and 7.7% of patients were not recovered from smell and taste disturbances during this period. Conclusion(s): Results showed that the commonest symptoms were headache, anosmia, ageusia, cough and dyspnea. This study confirmed high prevalence of smell/taste disorders in COVID-19 infection with self-recovery among half of the cases after nearly 2 weeks. Hence the symptoms could be considered as early identifiers/ markers and those helped in early detection and isolation of the patients for further management. Copyright © 2023, Dr Yashwant Research Labs Pvt Ltd. All rights reserved.

4.
1st International Conference on Technologies for Smart Green Connected Society 2021, ICTSGS 2021 ; 107:12625-12636, 2022.
Artigo em Inglês | Scopus | ID: covidwho-1874850

RESUMO

COVID-19 (CoronaVirus disease) is caused by coronavirus which leads to mild to moderate symptoms like cough,sneezing. It causes severe acute respiratory syndrome. India has the third highest number of COVID-19 confirmed cases in the world. The COVID-19 analysis was about the estimation of confirmed, death and recovered cases across India. The aim of the study was to introduce the Novel Ridge Regularization model for effective prediction of COVID-19 cases, therefore by reducing the overfitting of data. In this study two groups were used for classification namely Ridge regularization with sample size of 110 and SVM (Support Vector Machine) technique with sample size of 110, similarly the dataset size of 65896 was used for this experiment. Based on the experiment it was observed that the ridge regularization has got Least RMSE values than the SVM model with significance p=0.032. Ridge Regularization model provides a better approach for analyzing COVID-19 cases than SVM model. © The Electrochemical Society

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA